Skip to main content
. 2017 Feb 16;22(7):30464. doi: 10.2807/1560-7917.ES.2017.22.7.30464

Table 1. Influenza A(H3N2) cases and controls included in the 2016/17 season influenza vaccine effectiveness analysis, I-MOVE/I-MOVE+ multicentre case control studies (primary care (n = 5,023) and hospital (n = 635) levels) Europe, influenza season 2016/17 .

Variables Primary care level Hospital level
Number of A(H3N2) n = 2,250 Number of controls
n = 2,773
Number of A(H3N2)
n = 267
Number of controls
n = 368
n Total % n Total % n Total % n Total %
Median age (years) 29 28 79 80
Age groups (years)
0–4 276 2,242 12.3 723 2,766 26.1 NA NA
5–14 508 2,242 22.7 336 2,766 12.1 NA NA
15–64 1,177 2,242 52.5 1,438 2,766 52.0 NA NA
65–79 234 2,242 10.4 214 2,766 7.7 138 267 51.7 185 368 50.3
≥ 80 47 2,242 2.1 55 2,766 2.0 129 267 48.3 183 368 49.7
Missing 8 7 0 0
Sex
Female 1,126 2,237 50.3 1,407 2,758 51.0 141 267 52.8 190 368 51.6
Missing 13 15 0 0
Chronic conditions
At least one chronic condition 451 2,237 20.2 542 2,743 19.8 237 255 92.9 321 344 93.3
Missing 13 30 12 24
At least one hospitalisation in the previous 12 months for chronic conditions 26 2,196 1.2 57 2,686 2.1 66 247 26.7 146 334 43.7
Missing 54 87 20 34
Target group for vaccination
Belongs to a target group for vaccination 616 2,241 27.5 706 2,755 25.6 267 267 100.0 368 368 100.0
Missing 9 18 0 0
Swab delay
Swabbed within 3 days of symptom onset 2,024 2,250 90.0 2,291 2,773 82.6 154 267 57.7 212 368 57.6
Vaccination status
Seasonal flu vaccination 16–17 231 2,250 10.3 301 2,773 10.9 108 267 40.4 191 368 51.9
Seasonal flu vaccination 15–16 223 2,196 10.2 316 2,665 11.9 117 252 46.4 199 362 55.0
Missing 54 108 15 6
Previous and current season influenza vaccination
Not vaccinated in any season 1,929 2,196 87.8 2,284 2,665 85.7 128 252 50.8 147 362 40.6
Current season vaccination only 44 2,196 2.0 65 2,665 2.4 7 252 2.8 16 362 4.4
Previous season vaccination only 43 2,196 2.0 95 2,665 3.6 20 252 7.9 28 362 7.7
Current and previous season vaccination 180 2,196 8.2 221 2,665 8.3 97 252 38.5 171 362 47.2
Missing 54 108 15 6
Type of vaccine
Not vaccinated 2019 2,215 91.2 2,472 2,725 90.7 159 261 60.9 177 359 49.3
Inactivated subunit egg 97 2,215 4.4 108 2,725 4.0 65 261 24.9 101 359 28.1
Inactivated split virion egg 71 2,215 3.2 118 2,725 4.3 32 261 12.3 74 359 20.6
Adjuvanted 18 2,215 0.8 21 2,725 0.8 5 261 1.9 7 359 1.9
Quadrivalent vaccine 10 2,215 0.5 6 2,725 0.2 0 261 0.0 0 359 0.0
Missing vaccine type 35 48 6 9
Month of onset
October 2016 4 2,250 0.2 84 2,773 3.0 0 267 0.0 0 368 0.0
November 2016 154 2,250 6.8 759 2,773 27.4 3 267 1.1 6 368 1.6
December 2016 1,199 2,250 53.3 1,194 2,773 43.1 174 267 65.2 236 368 64.1
January 2017 893 2,250 39.7 736 2,773 26.5 90 267 33.7 126 368 34.2
Study sites
Croatia 13 2,250 0.6 13 2,773 0.5 NA NA
Finland NA NA 14 267 5.2 17 368 4.6
France 584 2,250 26.0 609 2,773 22.0 35 267 13.1 116 368 31.5
Germany 28 2,250 12.8 873 2,773 31.5 NA NA
Hungary 39 2,250 1.7 84 2,773 3.0 NA NA
Ireland 135 2,250 6.0 113 2,773 4.1 NA NA
Italy 411 2,250 18.3 367 2,773 13.2 37 267 13.9 58) 368 15.8
Lithuania NA NA 30 267 11.2 18 368 4.9
Navarra NA NA 20 267 7.5 34 368 9.2
The Netherlands 47 2,250 2.1 142 2,773 5.1 6 267 2.2 19 368 5.2
Poland 9 2,250 0.4 33 2,773 1.2 NA NA
Portugal 156 2,250 6.9 80 2,773 2.9 36 267 13.5 14 368 3.8
Romania 27 2,250 1.2 9 2,773 0.3 60 267 22.5 37 368 10.1
Spain 474 2,250 21.1 303 2,773 10.9 29 267 10.9 55 368 14.9
Sweden 66 2,250 2.9 147 2,773 5.3 NA NA

NA: Not applicable.